$SCYX
SCYNEXIS Inc

2018 Q3 Form 10-Q Financial Statement

#000156459018029141 Filed on November 13, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3 2017 Q2
Revenue $64.00K $64.00K $64.00K
YoY Change 0.0% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.433M $2.004M $2.361M
YoY Change 21.41% 6.6% 41.12%
% of Gross Profit
Research & Development $3.933M $4.459M $4.448M
YoY Change -11.8% -8.81% -33.2%
% of Gross Profit
Depreciation & Amortization $20.00K $0.00 $40.00K
YoY Change 300.0%
% of Gross Profit
Operating Expenses $6.366M $6.463M $6.809M
YoY Change -1.5% -4.53% -18.28%
Operating Profit -$6.302M -$6.399M -$6.745M
YoY Change -1.52% -4.58% -18.42%
Interest Expense $435.0K -$2.000M $360.0K
YoY Change -121.75%
% of Operating Profit
Other Income/Expense, Net $6.653M -$2.002M $2.546M
YoY Change -432.32% -55.73% 1718.57%
Pretax Income $350.0K -$8.400M -$4.200M
YoY Change -104.17% -25.2% -48.34%
Income Tax
% Of Pretax Income
Net Earnings $351.0K -$8.401M -$4.199M
YoY Change -104.18% -25.18% -48.34%
Net Earnings / Revenue 548.44% -13126.56% -6560.94%
Basic Earnings Per Share $0.01 -$0.31
Diluted Earnings Per Share $0.01 -$0.31 -$1.628M
COMMON SHARES
Basic Shares Outstanding 46.99M 27.09M 25.80M shares
Diluted Shares Outstanding 47.03M 27.09M

Balance Sheet

Concept 2018 Q3 2017 Q3 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.50M $47.70M $49.30M
YoY Change 3.77% -8.97% -1.99%
Cash & Equivalents $16.08M $8.749M $7.450M
Short-Term Investments $33.40M $39.00M $41.90M
Other Short-Term Assets $51.00K $86.00K $24.00K
YoY Change -40.7% 22.86% -60.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.24M $48.70M $50.85M
YoY Change 3.15% -10.13% -3.57%
LONG-TERM ASSETS
Property, Plant & Equipment $462.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $573.0K $900.0K $652.0K
YoY Change -36.33% 108.82% 53.05%
Total Long-Term Assets $1.415M $919.0K $981.0K
YoY Change 53.97% -86.53% 24.81%
TOTAL ASSETS
Total Short-Term Assets $50.24M $48.70M $50.85M
Total Long-Term Assets $1.415M $919.0K $981.0K
Total Assets $51.65M $49.62M $51.84M
YoY Change 4.09% -18.67% -3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.975M $1.832M $1.738M
YoY Change 7.81% -25.77% 52.99%
Accrued Expenses $1.403M $1.737M $1.329M
YoY Change -19.23% 33.0% -54.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.349M $2.849M $1.349M
YoY Change 157.95%
Total Short-Term Liabilities $11.09M $6.675M $4.673M
YoY Change 66.08% 65.3% 3.32%
LONG-TERM LIABILITIES
Long-Term Debt $7.617M $11.70M $13.10M
YoY Change -34.91% -17.39%
Other Long-Term Liabilities $5.100M $4.000M $2.400M
YoY Change 27.5% -58.33% -52.94%
Total Long-Term Liabilities $7.617M $11.70M $13.10M
YoY Change -34.91% -17.39% 156.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.09M $6.675M $4.673M
Total Long-Term Liabilities $7.617M $11.70M $13.10M
Total Liabilities $23.77M $22.36M $20.18M
YoY Change 6.33% -19.69% 109.13%
SHAREHOLDERS EQUITY
Retained Earnings -$219.7M -$197.7M -$189.3M
YoY Change 11.13% 11.88% 14.39%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.88M $27.26M $31.66M
YoY Change
Total Liabilities & Shareholders Equity $51.65M $49.62M $51.84M
YoY Change 4.09% -18.67% -3.16%

Cashflow Statement

Concept 2018 Q3 2017 Q3 2017 Q2
OPERATING ACTIVITIES
Net Income $351.0K -$8.401M -$4.199M
YoY Change -104.18% -25.18% -48.34%
Depreciation, Depletion And Amortization $20.00K $0.00 $40.00K
YoY Change 300.0%
Cash From Operating Activities -$6.150M -$5.250M -$7.380M
YoY Change 17.14% -23.36% -17.91%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $15.01M $2.950M -$6.970M
YoY Change 408.81% -118.91% -44.11%
Cash From Investing Activities $14.94M $2.950M -$6.970M
YoY Change 406.44% -118.9% -44.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 520.0K 3.600M 1.880M
YoY Change -85.56% -75.0% -91.18%
NET CHANGE
Cash From Operating Activities -6.150M -5.250M -7.380M
Cash From Investing Activities 14.94M 2.950M -6.970M
Cash From Financing Activities 520.0K 3.600M 1.880M
Net Change In Cash 9.310M 1.300M -12.47M
YoY Change 616.15% -116.13% 7693.75%
FREE CASH FLOW
Cash From Operating Activities -$6.150M -$5.250M -$7.380M
Capital Expenditures -$70.00K $0.00 $0.00
Free Cash Flow -$6.080M -$5.250M -$7.380M
YoY Change 15.81% -23.25% -17.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Assets
Assets
51650000
CY2017Q4 us-gaap Assets
Assets
45850000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1975000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3833000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1403000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1705000
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
185000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
257000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26096046
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47025503
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27091061
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22265000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19398000
CY2018Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
33408000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
576000
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
55000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
44960000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16080000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11469000
CY2017Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
32424000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
692000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1067000
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2018Q3 us-gaap Assets Current
AssetsCurrent
50235000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
573000
CY2018Q3 us-gaap Deferred Costs
DeferredCosts
107000
CY2017Q4 us-gaap Deferred Costs
DeferredCosts
314000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
273000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11086000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10144000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3933000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4459000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21193000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19159000
CY2018Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
103000
CY2017Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14858000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2433000
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7349000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4349000
CY2018Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
174000
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2018Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
121000
CY2018Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5068000
CY2017Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3872000
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7617000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10303000
CY2018Q3 us-gaap Liabilities
Liabilities
23771000
CY2017Q4 us-gaap Liabilities
Liabilities
24440000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2018Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
47000
CY2017Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
29000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
247492000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
226631000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219660000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-205250000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
27879000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21410000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51650000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45850000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47193062
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28971651
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47193062
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28971651
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12927000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2004000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6528000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6425000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
6366000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
6463000
us-gaap Operating Expenses
OperatingExpenses
21386000
us-gaap Operating Expenses
OperatingExpenses
19352000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6302000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6399000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46988844
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27091061
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42519585
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
314000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
300000
CY2018Q3 us-gaap Interest Income Other
InterestIncomeOther
260000
CY2017Q3 us-gaap Interest Income Other
InterestIncomeOther
109000
us-gaap Interest Expense
InterestExpense
1211000
us-gaap Interest Expense
InterestExpense
1081000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7611000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2809000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6783000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1689000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
351000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-8401000
us-gaap Net Income Loss
NetIncomeLoss
-14410000
us-gaap Net Income Loss
NetIncomeLoss
-17470000
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42519585
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26096046
us-gaap Profit Loss
ProfitLoss
-14410000
us-gaap Profit Loss
ProfitLoss
-17470000
us-gaap Depreciation
Depreciation
19000
us-gaap Depreciation
Depreciation
40000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1351000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1241000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
119000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-151000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
314000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
300000
scyx Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-4000
scyx Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-7000
scyx Write Off Of Deferred Filing Costs
WriteOffOfDeferredFilingCosts
230000
scyx Write Off Of Deferred Filing Costs
WriteOffOfDeferredFilingCosts
0
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-323000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
743000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2165000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
92000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-193000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-193000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
61042000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
45377000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
477000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
61963000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
61558000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1398000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16183000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30699000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8926000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
288000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
36000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8674000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4939000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-26907000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11469000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35656000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16408000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8749000
us-gaap Interest Paid Net
InterestPaidNet
1176000
us-gaap Interest Paid Net
InterestPaidNet
1081000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
601000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
393000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
84000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
27000
CY2018Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
12000
CY2017Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
32419000
CY2018Q3 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
230000
CY2017Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
609000
CY2018Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
795000
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
763000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
367000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
304000
CY2018Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
33407000
CY2018Q3 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
51000
CY2017Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
384000
CY2018Q3 us-gaap Prepaid Insurance
PrepaidInsurance
317000
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
279000
CY2018Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
98000
CY2017Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
62000
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
51000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
91000
CY2018Q3 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
175000000
CY2018Q3 scyx Aggregate Amount Receivable Upon Exercise Of Warrants
AggregateAmountReceivableUponExerciseOfWarrants
53000000
CY2013Q3 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
1500000
CY2013Q3 scyx Deferred Revenue Estimated Performance Period
DeferredRevenueEstimatedPerformancePeriod
P70M
CY2018Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
175000
CY2017Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
251000
CY2017Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
32424000
CY2018Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
33408000
CY2017Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
74000
CY2018Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
11000
CY2017Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
79000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
The Company has the option to renew for two consecutive five-year periods from the end of the first term. Under the lease, the Company must furnish a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which will be reduced by fifty-five thousand dollars every two years for ten years after the commencement of the lease
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
164000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
498000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
508000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
518000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
529000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4919000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7136000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.66
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.40
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.99
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.40
CY2018Q3 scyx Number Of License Agreements
NumberOfLicenseAgreements
2
CY2018Q3 scyx Additional Milestone Payments Maximum
AdditionalMilestonePaymentsMaximum
2300000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
31656000
CY2017Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
1000
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
407000
CY2017Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
18000
CY2017Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3583000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
27264000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
34819000
us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
0
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1241000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
36000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8638000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
458000
CY2018Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
21000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
498000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-2000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1351000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
39000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19498000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-9000
CY2018Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
30405457
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8076576
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17751500
CY2018Q3 scyx Fair Value Of Liabilities
FairValueOfLiabilities
5200000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3075994
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1217935
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
183821
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4110108
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2175665
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4110108
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.59
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.75
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y11M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M14D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
151000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
458000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
407000
CY2018Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2017Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2018Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2017Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3872000
scyx Derivative Fair Value Gain Loss From Mark To Market Adjustment
DerivativeFairValueGainLossFromMarkToMarketAdjustment
7611000
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5242000

Files In Submission

Name View Source Status
0001564590-18-029141-index-headers.html Edgar Link pending
0001564590-18-029141-index.html Edgar Link pending
0001564590-18-029141.txt Edgar Link pending
0001564590-18-029141-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20180930.htm Edgar Link pending
scyx-20180930.xml Edgar Link completed
scyx-20180930.xsd Edgar Link pending
scyx-20180930_cal.xml Edgar Link unprocessable
scyx-20180930_def.xml Edgar Link unprocessable
scyx-20180930_lab.xml Edgar Link unprocessable
scyx-20180930_pre.xml Edgar Link unprocessable
scyx-ex311_6.htm Edgar Link pending
scyx-ex312_7.htm Edgar Link pending
scyx-ex321_8.htm Edgar Link pending
Show.js Edgar Link pending